Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4095)
All Articles published online
|
Mar 15, 2010 (publication date) through Nov 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gatto M, Alvaro D. New insights on cholangiocarcinoma. World J Gastrointest Oncol 2010; 2(3): 136-145 [PMID: 21160821 DOI: 10.4251/wjgo.v2.i3.136] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v2/i3/136.htm |
| Number | Citing Articles |
| 1 |
Vincenzo Cardinale, Maria Consiglia Bragazzi, Guido Carpino, Alessia Torrice, Yunfang Wang, Lola McAdams Reid, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinomas: New Insights from the Discovery of Stem Cell Niches in Peribiliary Glands of the Biliary Tree. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/794953
|
| 2 |
J. Munding, A. Tannapfel. Anatomisch-pathologische Besonderheiten der Klatskin-Tumoren. Der Chirurg 2012; 83(3): 208 doi: 10.1007/s00104-011-2175-8
|
| 3 |
Ahmed Abdel-Razik, Youssif ElMahdy, Ehab El hanafy, Rania Elhelaly, Rasha Elzehery, Ahmed M. Tawfik, Waleed Eldars. Insulin-Like Growth Factor-1 and Vascular Endothelial Growth Factor in Malignant and Benign Biliary Obstructions. The American Journal of the Medical Sciences 2016; 351(3): 259 doi: 10.1016/j.amjms.2015.12.013
|
| 4 |
F Bernuzzi, F Marabita, A Lleo, M Carbone, M Mirolo, M Marzioni, G Alpini, D Alvaro, K M Boberg, M Locati, G Torzilli, L Rimassa, F Piscaglia, X-S He, C L Bowlus, G-X Yang, M E Gershwin, P Invernizzi. Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma. Clinical and Experimental Immunology 2016; 185(1): 61 doi: 10.1111/cei.12776
|
| 5 |
Amy L. Collins, Sylwia Wojcik, James Liu, Wendy L. Frankel, Hansjuerg Alder, Lianbo Yu, Thomas D. Schmittgen, Carlo M. Croce, Mark Bloomston. A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma. Annals of Surgical Oncology 2014; 21(1): 133 doi: 10.1245/s10434-013-3240-y
|
| 6 |
Alexander Arnold, Marcus Bahra, Dido Lenze, Maren Bradtmöller, Katrin Guse, Claire Gehlhaar, Hendrik Bläker, Frank L. Heppner, Arend Koch. Genome wide DNA copy number analysis in cholangiocarcinoma using high resolution molecular inversion probe single nucleotide polymorphism assay. Experimental and Molecular Pathology 2015; 99(2): 344 doi: 10.1016/j.yexmp.2015.08.003
|
| 7 |
Francesco M. Serafini, David Radvinsky. The pathways of genetic transformation in cholangiocarcinogenesis. Cancer Genetics 2016; 209(12): 554 doi: 10.1016/j.cancergen.2016.07.004
|
| 8 |
F. Rassam, E. Roos, K. P. van Lienden, J. E. van Hooft, H. J. Klümpen, G. van Tienhoven, R. J. Bennink, M. R. Engelbrecht, A. Schoorlemmer, U. H. W. Beuers, J. Verheij, M. G. Besselink, O. R. Busch, T. M. van Gulik. Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience. Langenbeck's Archives of Surgery 2018; 403(3): 289 doi: 10.1007/s00423-018-1649-2
|
| 9 |
Benjaporn Buranrat. In Vitro Evaluation of the Antiproliferative Activity of Piper Retrofractum on Human Cholangiocarcinoma Cells. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4112138
|
| 10 |
Aman Tedasen, Araya Khoka, Siribhorn Madla, Somchai Sriwiriyajan, Potchanapond Graidist. Anticancer effects of piperine-free Piper nigrum extract on cholangiocarcinoma cell lines. Pharmacognosy Magazine 2020; 16(68): 28 doi: 10.4103/pm.pm_288_19
|
| 11 |
Baiyin Zhong, Qicheng Liao, Xin Wang, Xiaonong Wang, Jianhong Zhang. The roles of epigenetic regulation in cholangiocarcinogenesis. Biomedicine & Pharmacotherapy 2023; 166: 115290 doi: 10.1016/j.biopha.2023.115290
|
| 12 |
Kumar Sandrasegaran, Christine O. Menias. Imaging and Screening of Cancer of the Gallbladder and Bile Ducts. Radiologic Clinics of North America 2017; 55(6): 1211 doi: 10.1016/j.rcl.2017.06.005
|
| 13 |
ALENA MÜLLER, SAMARPITA BARAT, XI CHEN, KHAC CUONG BUI, PRZEMYSLAW BOZKO, NISAR P. MALEK, RUBEN R. PLENTZ. Comparative study of antitumor effects of bromelain and papain in human cholangiocarcinoma cell lines. International Journal of Oncology 2016; 48(5): 2025 doi: 10.3892/ijo.2016.3411
|
| 14 |
Detian Yuan, Shan Huang, Emanuel Berger, Lei Liu, Nina Gross, Florian Heinzmann, Marc Ringelhan, Tracy O. Connor, Mira Stadler, Michael Meister, Julia Weber, Rupert Öllinger, Nicole Simonavicius, Florian Reisinger, Daniel Hartmann, Rüdiger Meyer, Maria Reich, Marco Seehawer, Valentina Leone, Bastian Höchst, Dirk Wohlleber, Simone Jörs, Marco Prinz, Duncan Spalding, Ulrike Protzer, Tom Luedde, Luigi Terracciano, Matthias Matter, Thomas Longerich, Percy Knolle, Thomas Ried, Verena Keitel, Fabian Geisler, Kristian Unger, Einat Cinnamon, Eli Pikarsky, Norbert Hüser, Roger J. Davis, Darjus F. Tschaharganeh, Roland Rad, Achim Weber, Lars Zender, Dirk Haller, Mathias Heikenwalder. Kupffer Cell-Derived Tnf Triggers Cholangiocellular Tumorigenesis through JNK due to Chronic Mitochondrial Dysfunction and ROS. Cancer Cell 2017; 31(6): 771 doi: 10.1016/j.ccell.2017.05.006
|
| 15 |
Adrian P. Mansini, Estanislao Peixoto, Kristen M. Thelen, Cesar Gaspari, Sujeong Jin, Sergio A. Gradilone. The cholangiocyte primary cilium in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1245 doi: 10.1016/j.bbadis.2017.06.006
|
| 16 |
Carlos L. Antunes, Carlos L. Antunes, Tony Richard O. Almeida, Nélia Raposeiro, Belarmino Gonçalves, Paulo Almeida. Using a tubular electrode for radiofrequency ablation. COMPEL - The international journal for computation and mathematics in electrical and electronic engineering 2012; 31(4): 1077 doi: 10.1108/03321641211227320
|
| 17 |
Sirintip Boonjaraspinyo, Zhiliang Wu, Thidarut Boonmars, Sasithorn Kaewkes, Watchalin Loilome, Paiboon Sithithaworn, Isao Nagano, Yuzo Takahashi, Puangrat Yongvanit, Vajarabhongsa Bhudhisawasdi. Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. Parasitology International 2012; 61(1): 145 doi: 10.1016/j.parint.2011.07.008
|
| 18 |
Sascha A. Müller, Arianeb Mehrabi, Nuh N. Rahbari, Rene Warschkow, Heike Elbers, Christine Leowardi, Hamidreza Fonouni, Ignazio Tarantino, Peter Schemmer, Bruno M. Schmied, Markus W. Büchler. Allogeneic Blood Transfusion Does Not Affect Outcome After Curative Resection for Advanced Cholangiocarcinoma. Annals of Surgical Oncology 2014; 21(1): 155 doi: 10.1245/s10434-013-3226-9
|
| 19 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_29-1
|
| 20 |
Tae Min You, Kee-Deog Kim, Ho-Gul Jeong, Wonse Park. Mandibular metastasis of cholangiocarcinoma: A case report. Imaging Science in Dentistry 2015; 45(4): 247 doi: 10.5624/isd.2015.45.4.247
|
| 21 |
ELISA PAOLICCHI, PAOLA PACETTI, ELISA GIOVANNETTI, ANDREA MAMBRINI, MASSIMO ORLANDI, FRANCESCO CREA, ANTONELLO A. ROMANI, ROBERTA TARTARINI, ROMANO DANESI, GODEFRIDUS J. PETERS, MAURIZIO CANTORE. A single nucleotide polymorphism in EZH2 predicts overall survival rate in patients with cholangiocarcinoma. Oncology Letters 2013; 6(5): 1487 doi: 10.3892/ol.2013.1559
|
| 22 |
Tao Zhang, Li-Xin Zhu, Qi-Kai Sun, Li-Jian Chen, Ye-Ben Qian. CARD9 promotes cholangiocarcinoma by regulating the IL-17A/Hedgehog and the THEM4/AKT/mTOR signaling pathways. International Immunopharmacology 2024; 143: 113399 doi: 10.1016/j.intimp.2024.113399
|
| 23 |
Larisa E Vasilieva, Stefanos I Papadhimitriou, Spyros P Dourakis. Modern diagnostic approaches to cholangiocarcinoma. Hepatobiliary & Pancreatic Diseases International 2012; 11(4): 349 doi: 10.1016/S1499-3872(12)60192-1
|
| 24 |
Samarpita Barat, Przemyslaw Bozko, Xi Chen, Tim Scholta, Franziska Hanert, Julian Götze, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz. Targeting c‐MET by LY2801653 for treatment of cholangiocarcinoma. Molecular Carcinogenesis 2016; 55(12): 2037 doi: 10.1002/mc.22449
|
| 25 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 549 doi: 10.1007/978-3-319-26956-6_29
|
| 26 |
Paiboon Sithithaworn, Puangrat Yongvanit, Kunyarat Duenngai, Nadda Kiatsopit, Chawalit Pairojkul. Roles of liver fluke infection as risk factor for cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(5): 301 doi: 10.1002/jhbp.62
|
| 27 |
Pankaj Prasoon, Kohei Miura, Kizuki Yuza, Yuki Hirose, Jun Sakata, Toshifumi Wakai. Bile Duct Cancer. 2019; doi: 10.5772/intechopen.82113
|
| 28 |
Patricia Marti, Claudia Stein, Tanja Blumer, Yann Abraham, Michael T. Dill, Monika Pikiolek, Vanessa Orsini, Giorgia Jurisic, Philippe Megel, Zuzanna Makowska, Claudia Agarinis, Luigi Tornillo, Tewis Bouwmeester, Heinz Ruffner, Andreas Bauer, Christian N. Parker, Tobias Schmelzle, Luigi M. Terracciano, Markus H. Heim, Jan S. Tchorz. YAP promotes proliferation, chemoresistance, and angiogenesis in human cholangiocarcinoma through TEAD transcription factors. Hepatology 2015; 62(5): 1497 doi: 10.1002/hep.27992
|
| 29 |
Bendong Chen, Wenyan Zhou, Wenchao Zhao, Peng Yuan, Chaofeng Tang, Genwang Wang, Junzhi Leng, Jinlong Ma, Xiaowen Wang, Yongfeng Hui, Qi Wang. Oxaliplatin reverses the GLP‑1R‑mediated promotion of intrahepatic cholangiocarcinoma by altering FoxO1 signaling. Oncology Letters 2019; doi: 10.3892/ol.2019.10497
|
| 30 |
Sarah JL Payne, Justin Stebbing, Peter Wilson, Sarah Slater. Outcomes in unresectable and locally advanced resected cholangiocarcinoma. Expert Review of Anticancer Therapy 2011; 11(5): 705 doi: 10.1586/era.11.32
|
| 31 |
Zi-Ying Lin, Zhen-Xing Liang, Pei-Lin Zhuang, Jie-Wei Chen, Yun Cao, Li-Xu Yan, Jing-Ping Yun, Dan Xie, Mu-Yan Cai. Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2827-7
|
| 32 |
Benjamin R. Kipp, Jesse S. Voss, Sarah E. Kerr, Emily G. Barr Fritcher, Rondell P. Graham, Lizhi Zhang, W. Edward Highsmith, Jun Zhang, Lewis R. Roberts, Gregory J. Gores, Kevin C. Halling. Isocitrate dehydrogenase 1 and 2 mutations in cholangiocarcinoma. Human Pathology 2012; 43(10): 1552 doi: 10.1016/j.humpath.2011.12.007
|
| 33 |
Bishwanath Acharya, Wanna Chaijaroenkul, Kesara Na-Bangchang. Atractylodin inhibited the migration and induced autophagy in cholangiocarcinoma cells via PI3K/AKT/mTOR and p38MAPK signalling pathways. Journal of Pharmacy and Pharmacology 2021; 73(9): 1191 doi: 10.1093/jpp/rgab036
|
| 34 |
Abhishek Shenoy, Neehar D. Parikh. CAQ Corner: Liver transplantation for rare hepatobiliary malignancies. Liver Transplantation 2023; 29(6): 644 doi: 10.1002/lt.26533
|
| 35 |
Arvind Srinath, Benjamin L. Shneider. Congenital Hepatic Fibrosis and Autosomal Recessive Polycystic Kidney Disease. Journal of Pediatric Gastroenterology and Nutrition 2012; 54(5): 580 doi: 10.1097/MPG.0b013e31824711b7
|
| 36 |
Mampei Yamashita, Tomohiko Adachi, Shinichiro Ono, Kyohei Yoshino, Hajime Imamura, Hajime Matsushima, Takayuki Tanaka, Taichiro Kosaka, Akihiko Soyama, Masaaki Hidaka, Kengo Kanetaka, Susumu Eguchi. Helicobacter bilis infection induces oxidative stress in and enhances the proliferation of human cholangiocytes. Helicobacter 2022; 27(4) doi: 10.1111/hel.12908
|
| 37 |
|
| 38 |
Carlos L. Antunes, Carlos L. Antunes, Tony Richard O. Almeida, Nélia Raposeiro. Saline‐enhanced RF ablation on a cholangiocarcinoma: a numerical simulation. COMPEL - The international journal for computation and mathematics in electrical and electronic engineering 2012; 31(4): 1055 doi: 10.1108/03321641211227302
|
| 39 |
Fany K. Segura‐López, Francisco Avilés‐Jiménez, Alfredo Güitrón‐Cantú, Hilda A. Valdéz‐Salazar, Samuel León‐Carballo, Leoncio Guerrero‐Pérez, James G. Fox, Javier Torres. Infection with Helicobacter bilis but not Helicobacter hepaticus was Associated with Extrahepatic Cholangiocarcinoma. Helicobacter 2015; 20(3): 223 doi: 10.1111/hel.12195
|
| 40 |
Thomas von Hahn, Sandra Ciesek, Gerd Wegener, Ruben R. Plentz, Tobias J. Weismüller, Heiner Wedemeyer, Michael P. Manns, Tim F. Greten, Nisar P. Malek. Epidemiological trends in incidence and mortality of hepatobiliary cancers in Germany. Scandinavian Journal of Gastroenterology 2011; 46(9): 1092 doi: 10.3109/00365521.2011.589472
|
| 41 |
Jamie E. Anderson, Alan W. Hemming, David C. Chang, Mark A. Talamini, Kristin L. Mekeel. Surgical Management Trends for Cholangiocarcinoma in the USA 1998–2009. Journal of Gastrointestinal Surgery 2012; 16(12): 2225 doi: 10.1007/s11605-012-1980-9
|
| 42 |
Mona El Khatib, Anna Kalnytska, Vindhya Palagani, Uta Kossatz, Michael P. Manns, Nisar P. Malek, Ludwig Wilkens, Ruben R. Plentz. Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma. Hepatology 2013; 57(3): 1035 doi: 10.1002/hep.26147
|
| 43 |
Domenico Alvaro, Vincenzo Cardinale. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 99 doi: 10.1007/978-3-642-40558-7_7
|
| 44 |
Surachate Siripongsakun, Sirachat Vidhyarkorn, Sirivipa Charuswattanakul, Poemlarp Mekraksakit, Prakongboon Sungkasubun, Nuphat Yodkhunnathum, Sutthirak Tangruangkiat, Napat Ritlumlert, Thaniya Sricharunrat, Sirima Jaroenpatarapesaj, Kamonwan Soonklang, Anond Kulthanmanusorn, Chirayu U Auewarakul, Chulabhorn Mahidol. Ultrasound surveillance for cholangiocarcinoma in an endemic area: A prove of survival benefits. Journal of Gastroenterology and Hepatology 2018; 33(7): 1383 doi: 10.1111/jgh.14074
|
| 45 |
Bo Tang, Jian Du, Yang Li, Fang Tang, Zhenran Wang, Songqing He. EZH2 elevates the proliferation of human cholangiocarcinoma cells through the downregulation of RUNX3. Medical Oncology 2014; 31(11) doi: 10.1007/s12032-014-0271-6
|
| 46 |
Kanawut Kotawong, Wanna Chaijaroenkul, Phunuch Muhamad, Kesara Na-Bangchang. Cytotoxic activities and effects of atractylodin and β-eudesmol on the cell cycle arrest and apoptosis on cholangiocarcinoma cell line. Journal of Pharmacological Sciences 2018; 136(2): 51 doi: 10.1016/j.jphs.2017.09.033
|
| 47 |
Rocio I. R. Macias. Cholangiocarcinoma: Biology, Clinical Management, and Pharmacological Perspectives. ISRN Hepatology 2014; 2014: 1 doi: 10.1155/2014/828074
|